Results

1–8 of 8 results for ANTIVEGF

Clinical Presentantion and Management of Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa
Cagri G Besirli, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2020
Fluctuations in Central Foveal Thickness and Vision Outcomes With AntiVEGF Therapy for Neovascular Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Updates from the Field
2020
One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Updates from the Field
2020
Progression of glaucoma after anti-VEGF injections in susceptible eyes- Dr. Eugene Shildkrot
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Episode 198: Journal Club about Online Physician Reviews, Systematic Review Reliability, SCORE2 24 month Data, Brolucizumab FDA Approval
Jayanth Sridhar, MD
Member Podcasts
2019
Episode 29: Anti-VEGF Levels in Breast Milk after Intravitreal Injections- Drs. Muni and Juncal
Keyvan Koushan, MD, FRCSC
Member Podcasts
Silicone Drop in Space of Martegiani
Patrick Reis Morais, MD
Retina Image Bank: Images of the Week
2015